New pharmacological approaches in the treatment of Tourette syndrome.
D000293:Adolescent; D000328:Adult; D000547:Amantadine / Q000627:therapeutic use; D001590:Benztropine / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic; D003000:Clonidine / Q000627:therapeutic use*; D005260:Female; D005476:Fluphenazine / Q000627:therapeutic use; D006220:Haloperidol / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D008297:Male; D005879:Tourette Syndrome / Q000188:drug therapy*; D014268:Trifluoperazine / Q000627:therapeutic use
D001590:Benztropine; D014268:Trifluoperazine; D008094:Lithium; D000547:Amantadine; D006220:Haloperidol; D003000:Clonidine; D005476:Fluphenazine